Zenotech Laboratories (532039.BO) Stock Price

Zenotech Laboratories Price

CLOSED
38.60
​
Market closed

Revenue has compounded at 3.2% per year over the past 19 years to 395.62 M INR. Earnings per share have grown at 2.8% per year over the last 18 years. Zenotech Laboratories's net margin stands at -2.7%, down from 60.6% several years earlier.

Zenotech Laboratories stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories business model & stock analysis

Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications.

Frequently asked questions about Zenotech Laboratories

Converted at the current exchange rate, the Zenotech Laboratories share trades at 0.38 EUR (38.60 INR).

The revenue of Zenotech Laboratories is 395.62 M INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Zenotech Laboratories is -10.72 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Zenotech Laboratories is currently -219.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Zenotech Laboratories stock.

The price-to-sales ratio (P/S) of Zenotech Laboratories is currently 5.95. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Zenotech Laboratories stock.

The Eulerpool Quality Score for Zenotech Laboratories is 2/10.

The ISIN of Zenotech Laboratories is INE486F01012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Zenotech Laboratories is 532039.BO. The ticker symbol is used to trade Zenotech Laboratories shares on the stock exchange.

Fair ValueTerminal
38.21 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
2.64 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
May 14, 1996
ISIN
INE486F01012
Cusip
Y82972103
Market capitalization
2.36 B INRMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.48
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.13 %
Last updated Nov 22, 2026, 3:46 AM

Zenotech Laboratories Peer Group

Zenotech Laboratories FIGI

ZTL:IN · BBG000HHP041ZTL:IB · BBG000HHP103